These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 11712064

  • 1. Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).
    Ravenscroft J, Goulden V, Wilkinson M.
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S218-9. PubMed ID: 11712064
    [Abstract] [Full Text] [Related]

  • 2. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
    Takashima A, Yamamoto K, Kimura S, Takakuwa Y, Mizuno N.
    Br J Dermatol; 1991 Jan; 124(1):37-42. PubMed ID: 1993143
    [Abstract] [Full Text] [Related]

  • 3. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P, Ortel B, Carlino A, Honigsmann H, De Panfilis G.
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [Abstract] [Full Text] [Related]

  • 4. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG, Zane C, Carlino A, De Panfilis G.
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [Abstract] [Full Text] [Related]

  • 5. Contact allergy to 8-methoxypsoralen.
    Korffmacher H, Hartwig R, Matthes U, Dirschka T, Albassam A, Weindorf N, Altmeyer P.
    Contact Dermatitis; 1994 May; 30(5):283-5. PubMed ID: 8088142
    [Abstract] [Full Text] [Related]

  • 6. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
    Aubin F, Makki S, Humbert P, Muret P, Agache P.
    Arch Dermatol Res; 1994 May; 286(1):30-4. PubMed ID: 8141609
    [Abstract] [Full Text] [Related]

  • 7. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation.
    Tanew A, Ortel B, Rappersberger K, Hönigsmann H.
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):333-8. PubMed ID: 3279089
    [Abstract] [Full Text] [Related]

  • 8. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M, Ros AM.
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [Abstract] [Full Text] [Related]

  • 9. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
    Hönigsmann H, Jaschke E, Gschnait F, Brenner W, Fritsch P, Wolff K.
    Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
    [Abstract] [Full Text] [Related]

  • 10. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A, Pukkala E, Koulu L, Jansén CT, Karvonen J.
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of PUVA bath phototoxicity.
    Neumann NJ, Kerscher M, Ruzicka T, Lehmann P.
    Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
    [Abstract] [Full Text] [Related]

  • 12. Anaphylaxis to 5-methoxypsoralen during photochemotherapy.
    Legat FJ, Wolf P, Kränke B.
    Br J Dermatol; 2001 Nov; 145(5):821-2. PubMed ID: 11736909
    [Abstract] [Full Text] [Related]

  • 13. PUVA therapy for photosensitive psoriasis.
    Ros AM, Wennersten G.
    Acta Derm Venereol; 1987 Nov; 67(6):501-5. PubMed ID: 2451375
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis from 5-methoxypsoralen occurring in a patient with previous flucloxacillin hepatitis.
    Stephens RB, Cooper A.
    Australas J Dermatol; 1999 Nov; 40(4):217-9. PubMed ID: 10570561
    [Abstract] [Full Text] [Related]

  • 15. The time course of phototoxicity of topical PUVA: 8-methoxypsoralen cream-PUVA vs. 8-methoxypsoralen gel-PUVA.
    Grundmann-Kollmann M, Leiter U, Behrens S, Gottlöber P, Mooser G, Krähn G, Kerscher M.
    Br J Dermatol; 1999 May; 140(5):988-90. PubMed ID: 10354061
    [No Abstract] [Full Text] [Related]

  • 16. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
    Yang XY, Gasparro FP, DeLeo VA, Santella RM.
    J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
    [Abstract] [Full Text] [Related]

  • 17. Mutagenicity and carcinogenicity of methoxsalen plus UV-A.
    Roelandts R.
    Arch Dermatol; 1984 May; 120(5):662-9. PubMed ID: 6372701
    [Abstract] [Full Text] [Related]

  • 18. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
    Grundmann-Kollmann M, Podda M, Bräutigam L, Hardt-Weinelt K, Ludwig RJ, Geisslinger G, Kaufmann R, Tegeder I.
    Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A, Hofer A, Legat F, Kerl H, Wolf P.
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [Abstract] [Full Text] [Related]

  • 20. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE, Panizzon RG.
    Dermatology; 1999 Mar; 199(2):106-12. PubMed ID: 10559574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.